tiprankstipranks
Trending News
More News >
CytomX Therapeutics Inc (CTMX)
NASDAQ:CTMX

CytomX Therapeutics (CTMX) Revenue

Compare
703 Followers

CytomX Therapeutics Revenue

CytomX Therapeutics had a revenue of 38.09M in the quarter ending Dec 31, 2024, with 13.94%. This bring the company's revenue in the last twelve months to 138.10M, Decreased 9.07%. In the fiscal year ending Dec 31, 2024, CytomX Therapeutics had annual revenue of 138.10M with 36.45% growth.
Revenue (ttm)
138.10M
Revenue Growth
23.81%
P/S Ratio
2.35
Revenue/Employee
$1,160,529
Employees
119
Market Cap
$324.54M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
138.10M36.89M+36.45%
Dec 31, 2023
101.21M48.05M+90.38%
Dec 31, 2022
53.16M-16.41M-23.59%
Dec 31, 2021
69.57M-30.79M-30.68%
Dec 31, 2020
100.36M42.87M+74.58%
Dec 31, 2019
57.49M-2.01M-3.38%
Dec 31, 2018
59.50M-12.12M-16.92%
Dec 31, 2017
71.62M56.58M+376.12%
Dec 31, 2016
15.04M7.33M+95.06%
Dec 31, 2015
7.71M2.63M+51.90%
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis